Oncogene: An International Journal

• 

  Año 2004, Número 3

  • p53 protein variants: structural and functional similarities with p63 and p73 isoforms

    S. Courtois, C. C. Fromentel

    págs. 631-638

    

  • Manipulation of nonsense mediated decay identifies gene mutations in colon cancer Cells with microsatellite instability

    M. Perucho, Y. Ionov, N. Nowak, S. Markowitz, J. K. Cowell

    págs. 639-645

    

  • Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016

    W. Xia, L. H. Liu

    págs. 646-653

    

  • Identification of IGFBP-6 as a significantly downregulated gene by ß-catenin in desmoid tumors

    H. Denys, A. Jadidizadeh

    págs. 654-664

    

  • Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RAR¿

    M. A. Sukhai

    págs. 665-678

    

  • The human hepatocyte growth factor (HGF) gene is transcriptionally activated by leukemia inhibitory factor through the Stat binding element

    M. Tomida, T. Saito

    págs. 679-686

    

  • p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis

    Jing Gao, H. Y. Huang

    págs. 687-696

    

  • Downregulation of Muc1 in MMTV-c-Neu tumors

    M. C. Adriance, S. J. Gendler

    págs. 697-705

    

  • Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylgeranyltransferase I inhibitor-induced apoptosis

    K. Jiang, D. Coppola, S. V. Nicosia, A. Hamilton, H. C. Dan

    págs. 706-715

    

  • C/EBP¿p30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding

    Alan D Friedman, Qian-Fei Wang, Rebecca Cleaves

    págs. 716-725

    

  • STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression

    A. Joo, H. Aburatani

    págs. 726-734

    

  • The absence of p53 is critical for the induction of apoptosis by 5-aza-2¿-deoxycytidine

    E. Samper, G. Gonzalez de Buitrago, M. Nieto, M. F. Fraga

    págs. 735-743

    

  • A novel time-course cDNA microarray analysis method identifies genes associated with the development of cisplatin resistance

    M. A. Whiteside

    págs. 744-752

    

  • MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma

    C. F. Manohar

    págs. 753-762

    

  • The MAP kinase pathway is required for entry into mitosis and cell survival

    S. R. Yan, R. L. Erikson, Xiaoqi Liu, T. Zhou, Y. Terada

    págs. 763-776

    

  • High-mobility group A1a protein regulates Ras/ERK signaling in MCF-7 human breast cancer cells

    G. A. Dement, N. R. Treff, D. Pouchnik

    págs. 777-785

    

  • PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells

    H. Zhao, J. Dupont

    págs. 786-794

    

  • Gene expression analysis reveals evidence for inactivation of the TGF-ß signaling cascade in autonomously functioning thyroid nodules

    M. Eszlinger

    págs. 795-804

    

  • Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos

    L. Scapoli, M. E. Ramos-Nino

    págs. 805-813

    

  • Differences in stability of repressor complexes at promoters underlie distinct roles for Rb family members

    G. D. Longmore, A. P. Young

    págs. 814-823

    

  • Caffeine inhibits homology-directed repair of I-SceI-induced DNA double-strand breaks

    H. Wang, W. Boecker

    págs. 824-834

    

  • Divergence of Genbank and human tumor Bcl-2 sequences and implications for binding affinity to key apoptotic proteins

    M. K. Joseph, L. R. Solomon

    págs. 835-838

    

  • Transcriptional repressor BCL-6 immortalizes germinal center-like B cells in the absence of p53 function

    S. Kusam, F. H. Vasanwala

    págs. 839-844

    

  • MMP expression profiling in recurred stage IB lung cancer

    K. P. Hong, N. H. Cho, S. H. Hong

    págs. 845-851

    

  • Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer

    N. Hu, C. Wang, X. Y. Han

    págs. 852-858

    

  • Loss of chromosome 18q and DPC4 (Smad4) mutations in appendiceal adenocarcinomas

    D. Maru, A. Canada, P. S. Houlihan, S. R. Hamilton, T. T. Wu

    págs. 859-864